Article
Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA).
British journal of cancer - 15 Dec 2009
Osorio A, Milne R L, Pita G, Peterlongo P, Heikkinen T, Simard J, Chenevix-Trench G, Spurdle A B, Beesley J, Chen X, Healey S, Neuhausen S L, Ding Y C, Couch F J, Wang X, Lindor N, Manoukian S, Barile M, Viel A, Tizzoni L, Szabo C I, Foretova L, Zikan M, Claes K, Greene M H, Mai P, Rennert G, Lejbkowicz F, Barnett-Griness O, Andrulis I L, Ozcelik H, Weerasooriya N, Gerdes A-M, Thomassen M, Cruger D G, Caligo M A, Friedman E, Kaufman B, Laitman Y, Cohen S, Kontorovich T, Gershoni-Baruch R, Dagan E, Jernström H, Askmalm M S, Arver B, Malmer B, Domchek S M, Nathanson K L, Brunet J, Ramón Y Cajal T, Yannoukakos D, Hamann U, Hogervorst F B L, Verhoef S, Gómez García E B, Wijnen J T, van den Ouweland A, Easton D F, Peock S, Cook M, Oliver C T, Frost D, Luccarini C, Evans D G, Lalloo F, Eeles R, Pichert G, Cook J, Hodgson S, Morrison P J, Douglas F, Godwin A K, Sinilnikova O M, Barjhoux L, Stoppa-Lyonnet D, Moncoutier V, Giraud S, Cassini C, Olivier-Faivre L, Révillion F, Peyrat J-P, Muller D, Fricker J-P, Lynch H T, John E M, Buys S, Daly M, Hopper J L, Terry M B, Miron A, Yassin Y, Goldgar D, Singer C F, Gschwantler-Kaulich D, Pfeiler G, Spiess A-C, Hansen Thomas V O, Johannsson O T, Kirchhoff T, Offit K, Kosarin K, Piedmonte M, Rodriguez G C, Wakeley K, Boggess J F, Basil J, Schwartz P E, Blank S V, Toland A E, Montagna M, Casella C, Imyanitov E N, Allavena A, Schmutzler R K, Versmold B, Engel C, Meindl A, Ditsch N, Arnold N, Niederacher D, Deissler H, Fiebig B, Varon-Mateeva R, Schaefer D, Froster U G, Caldes T, de la Hoya M, McGuffog L, Antoniou A C, Nevanlinna H, Radice P, Benítez J
Abstract excerpt
BACKGROUND: In this study we aimed to evaluate the role of a SNP in intron 1 of the ERCC4 gene (rs744154), previously reported to be associated with a reduced risk of breast cancer in the general population, as a breast cancer risk modifier in BRCA1 and BRCA2 mutation carriers. METHODS: We have g...
